The VIH-46, a modified version of the VIH-47 developed in French by Gerbaud based on the SF-36 and the MOS-HIV, was used as endpoint in a therapeutic educational program in HIV+. OBJECTIVE: To check the psychometric properties of the VIH-46 in the study population. The VIH-46 covers 11 Quality of Life (QoL) domains: Physical Functioning (PF), Role Physical (RP), Bodily Pain (BP), General Health (GH), Vitality (VT), Social Functioning (SF), Role Emotional (RE), Mental Health (MH), Activities of daily Living (ADL), Psychological Distress (PD), Cognitive Functioning (CF). METHODS: Three hundred twenty-six patients were analysed for cross-sectional analyses at baseline (BL) and 242 patients were analysed over the initial 6-month (M6) period. A Multitrait Analysis Program (MAP) was used to assess convergent and divergent item validity. Cronbach°|s f Ñ measured internal consistency reliability. Values d 0.7 were expected. Floor and ceiling effects were calculated. The clinical validity was assessed against Karnofski index, CD4+ count, and virus load. Responsiveness to change over time was assessed by Effect Sizes (ES) calculation in improved and impaired patients according to clinical change at M6. A value of 0.50 measures moderate responsiveness. RESULTS: At BL 89.6% patients had no missing data. All items matched the item-convergent validity criterion, and all items except two matched the item-discriminant validity criterion. Internal consistency reliability was satisfactory. Moderate (20%) to high (50%) ceiling effects were found in PF, RP, RE, SF, BP, ADL dimensions. The differences in QoL scores according to Karnofski Index, CD4+ level, and virus load, were limited. The ES were always less than moderate. CON-CLUSION: in the study population, the impact of compliance on QoL might be too complex to be captured by the VIH-46. In addition, the importance of ceiling effects suggests a limitation of the ability of the VIH-46 to detect improvements. (IDDQ) . Each item of the IDDQ is answered by indicating degree of agreement using a five point response scale (completely agree, agree, neither agree nor disagree, disagree, completely disagree) with eight sentences describing the effects of influenza on disruption of daily activities. METHODS: The IDDQ was administered daily in a clinical trial assessing influenza treatment. IDDQ psychometric properties were assessed by examining item response spreads, internal consistency, and factor analysis. IDDQ scores were examined by age, gender, and body mass index (BMI) and correlated with patient-reported physical symptoms (nasal congestion, sore throat, cough, aches and pains, fatigue, headache, chills/sweats). Item-response models were also applied. RESULTS: Factor analysis supported IDDQ unidimensionality; at each day only one component explaining around 90% of total variance was extracted. IDDQ construct validity was supported by significant correlation coefficients between most IDDQ items including the IDDQ total score and all seven symptoms, in terms of both day-to-day and AUC scores. While half of the items had well-distributed response ranges, for others patients used mainly one end of the scale. These same items were the least internally consistent and on Rasch analysis most likely to have reversed thresholds related to the mid-point response "neither agree nor disagree" (individual item fit p < 0.01). In general, there was only a low probability of subjects choosing the mid-point response option. The mid-point response was therefore dropped in a revised IDDQ, which has a 4-point response scale (completely agree, agree, disagree, completely disagree). CONCLU-SIONS: The revised IDDQ with a four-point response scale has acceptable psychometric properties. Further use of the revised IDDQ is recommended, especially in community-based epidemiological studies that may capture a broader spectrum of severity of influenza that usually seen in clinical studies. 
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INVESTIGATION INTO THE FEASIBILITY OF DERIVING RELATIVE AND ABSOLUTE UTILITY FROM THE RECURRENT GENITAL HERPES QUALITY OF LIFE QUESTIONNAIRE (RGHQOL)
Doward
OBJECTIVES:
The Recurrent Genital Herpes Quality of Life questionnaire (RGHQoL) is a needs-based quality of life (QoL) instrument specific to recurrent genital herpes (RGH), with excellent psychometric properties. However, it cannot be used to directly derive utility. Existing utility instruments cover symptoms/functioning, rather than QoL, raising concerns over their relevance for RGH and
